by in Gene Therapy, Resource Center, Risk Management

Read our February 2025 update on the cell and gene therapy pipeline, with an in-depth look at Elevidys

Cell and Gene Therapy State of the Market | Winter 2025 was last modified: May 21st, 2025 by Samantha Smith
| a Berkley Company